{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:05:49Z","timestamp":1783181149954,"version":"3.54.6"},"reference-count":25,"publisher":"Japanese Society of Toxicology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2019]]},"DOI":"10.2131\/jts.44.47","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T17:59:25Z","timestamp":1546883965000},"page":"47-56","source":"Crossref","is-referenced-by-count":22,"title":["Galectin-3 regulates chemotherapy sensitivity in epithelial ovarian carcinoma via regulating mitochondrial function"],"prefix":"10.2131","volume":"44","author":[{"given":"Dawei","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Radiotherapy, the Affiliated Yantai Yuhuangding Hospital of Qingdao University, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"You","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, the Affiliated Yantai Yuhuangding Hospital of Qingdao University, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, the Affiliated Yantai Yuhuangding Hospital of Qingdao University, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Agarwal, R. and Kaye, S.B. (2003): Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat. Rev. Cancer, <b>3<\/b>, 502-516.","DOI":"10.1038\/nrc1123"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Ali, A.Y., Farrand, L., Kim, J.Y., Byun, S., Suh, J.Y., Lee, H.J. and Tsang, B.K. (2012): Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum. Ann. N. Y. Acad. Sci., <b>1271<\/b>, 58-67.","DOI":"10.1111\/j.1749-6632.2012.06734.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Barber, E.L., Dusetzina, S.B., Stitzenberg, K.B., Rossi, E.C., Gehrig, P.A., Boggess, J.F. and Garrett, J.M. (2017): Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival. Gynecol. Oncol., <b>145<\/b>, 500-507.","DOI":"10.1016\/j.ygyno.2017.03.014"},{"key":"4","unstructured":"Biswas, R., Ahn, J.C. and Kim, J.S. (2015): Sulforaphene Synergistically Sensitizes Cisplatin via Enhanced Mitochondrial Dysfunction and PI3K\/PTEN Modulation in Ovarian Cancer Cells. Anticancer Res., <b>35<\/b>, 3901-3908."},{"key":"5","doi-asserted-by":"crossref","unstructured":"Bristow, N., Burton, T.R., Henson, E.S., Ong-Justiniano, C., Brown, M. and Gibson, S.B. (2011): Truncated forms of BNIP3 act as dominant negatives inhibiting hypoxia-induced cell death. Biochim. Biophys. Acta, <b>1812<\/b>, 302-311.","DOI":"10.1016\/j.bbadis.2010.11.013"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Brown, R., Curry, E., Magnani, L., Wilhelm-Benartzi, C.S. and Borley, J. (2014): Poised epigenetic states and acquired drug resistance in cancer. Nat. Rev. Cancer, <b>14<\/b>, 747-753.","DOI":"10.1038\/nrc3819"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Cai, G., Ma, X., Chen, B., Huang, Y., Liu, S., Yang, H. and Zou, W. (2016): Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation. Tumour Biol., <b>37<\/b>, 11883-11891.","DOI":"10.1007\/s13277-016-5038-6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Chappell, N.P., Teng, P.N., Hood, B.L., Wang, G., Darcy, K.M., Hamilton, C.A., Maxwell, G.L. and Conrads, T.P. (2012): Mitochondrial proteomic analysis of cisplatin resistance in ovarian cancer. J. Proteome Res., <b>11<\/b>, 4605-4614.","DOI":"10.1021\/pr300403d"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Chen, L., Yao, Y., Sun, L. and Tang, J. (2017): Galectin-1 promotes tumor progression via NF-\u03baB signaling pathway in epithelial ovarian cancer. J. Cancer, <b>8<\/b>, 3733-3741.","DOI":"10.7150\/jca.20814"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Coukos, G. and Rubin, S.C. (1998): Chemotherapy resistance in ovarian cancer: new molecular perspectives. Obstet. Gynecol., <b>91<\/b>, 783-792.","DOI":"10.1097\/00006250-199805000-00028"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Dayan, F., Mazure, N.M., Brahimi-Horn, M.C. and Pouyss\u00e9gur, J. (2008): A dialogue between the hypoxia-inducible factor and the tumor microenvironment. Cancer Microenviron., <b>1<\/b>, 53-68.","DOI":"10.1007\/s12307-008-0006-3"},{"key":"12","doi-asserted-by":"publisher","unstructured":"Di Lella, S., Sundblad, V., Cerliani, J.P., Guardia, C.M., Estrin, D.A., Vasta, G.R. and Rabinovich, G.A. (2011): When galectins recognize glycans: from biochemistry to physiology and back again. Biochemistry, <b>50<\/b>, 7842-7857.","DOI":"10.1021\/bi201121m"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Dong, Y., Berners-Price, S.J., Thorburn, D.R., Antalis, T., Dickinson, J., Hurst, T., Qiu, L., Khoo, S.K. and Parsons, P.G. (1997): Serine protease inhibition and mitochondrial dysfunction associated with cisplatin resistance in human tumor cell lines: targets for therapy. Biochem. Pharmacol., <b>53<\/b>, 1673-1682.","DOI":"10.1016\/S0006-2952(97)00015-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J.W., Comber, H., Forman, D. and Bray, F. (2013): Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur. J. Cancer, <b>49<\/b>, 1374-1403.","DOI":"10.1016\/j.ejca.2012.12.027"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Hood, J.D. and Cheresh, D.A. (2002): Role of integrins in cell invasion and migration. Nat. Rev. Cancer, <b>2<\/b>, 91-100.","DOI":"10.1038\/nrc727"},{"key":"16","doi-asserted-by":"publisher","unstructured":"Hughes, R.C. (2001): Galectins as modulators of cell adhesion. Biochimie, <b>83<\/b>, 667-676.","DOI":"10.1016\/S0300-9084(01)01289-5"},{"key":"17","unstructured":"Kigawa, J., Sato, S., Shimada, M., Takahashi, M., Itamochi, H., Kanamori, Y. and Terakawa, N. (2001): p53 gene status and chemosensitivity in ovarian cancer. Hum. Cell, <b>14<\/b>, 165-171."},{"key":"18","doi-asserted-by":"crossref","unstructured":"Le, Q.T., Denko, N.C. and Giaccia, A.J. (2004): Hypoxic gene expression and metastasis. Cancer Metastasis Rev., <b>23<\/b>, 293-310.","DOI":"10.1023\/B:CANC.0000031768.89246.d7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Liu, F.T. and Rabinovich, G.A. (2005): Galectins as modulators of tumour progression. Nat. Rev. Cancer, <b>5<\/b>, 29-41.","DOI":"10.1038\/nrc1527"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Livak, K.J. and Schmittgen, T.D. (2001): Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Method. Methods, <b>25<\/b>, 402-408.","DOI":"10.1006\/meth.2001.1262"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Muz, B., de la Puente, P., Azab, F. and Azab, A.K. (2015): The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl.), <b>3<\/b>, 83-92.","DOI":"10.2147\/HP.S93413"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Nabi, I.R., Shankar, J. and Dennis, J.W. (2015): The galectin lattice at a glance. J. Cell Sci., <b>128<\/b>, 2213-2219.","DOI":"10.1242\/jcs.151159"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Vaughan, S., Coward, J.I., Bast, R.C. Jr., Berchuck, A., Berek, J.S., Brenton, J.D., Coukos, G., Crum, C.C., Drapkin, R., Etemadmoghadam, D., Friedlander, M., Gabra, H., Kaye, S.B., Lord, C.J., Lengyel, E., Levine, D.A., McNeish, I.A., Menon, U., Mills, G.B., Nephew, K.P., Oza, A.M., Sood, A.K., Stronach, E.A., Walczak, H., Bowtell, D.D. and Balkwill, F.R. (2011): Rethinking ovarian cancer: recommendations for improving outcomes. Nat. Rev. Cancer, <b>11<\/b>, 719-725.","DOI":"10.1038\/nrc3144"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Xiao, M., Cai, J., Cai, L., Jia, J., Xie, L., Zhu, Y., Huang, B., Jin, D. and Wang, Z. (2017): Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair. J. Ovarian Res., <b>10<\/b>, 24.","DOI":"10.1186\/s13048-017-0321-8"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Yasuda, H. (2008): Solid tumor physiology and hypoxia-induced chemo\/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer. Nitric Oxide, <b>19<\/b>, 205-216.","DOI":"10.1016\/j.niox.2008.04.026"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/44\/1\/44_47\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T13:38:12Z","timestamp":1573652292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/44\/1\/44_47\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.44.47","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}